Literature DB >> 2485070

Vascular angiotensin pathways: a new therapeutic target.

V J Dzau1.   

Abstract

The renin-angiotensin system affects blood pressure and regional blood flow through endocrine, paracrine, and autocrine influences. The circulating endocrine renin-angiotensin system (RAS) is activated for acute cardiovascular homeostasis. The recent demonstration of a local renin-angiotensin system in the blood vessel wall has led us to speculate that the local production of angiotensin is involved with autocrine and paracrine control of vascular resistance. In addition to producing arteriolar constriction, arterial wall renin-angiotensin may influence the compliance of large conduit arteries. The production of angiotensin in the blood vessels may participate in hypertension and may influence blood pressure responses to the inhibitors of the RAS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2485070

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

Review 1.  Cardiovascular therapies in the 1990s. An overview.

Authors:  R C Becker; J M Gore
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 2.  ACE-inhibitors and atherosclerosis.

Authors:  E Ambrosioni; S Bacchelli; D Degli Esposti; C Borghi
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

3.  The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man.

Authors:  J R Wade; P A Meredith; D M Hughes; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

Review 4.  Endothelial dysfunction: a comprehensive appraisal.

Authors:  Ricardo J Esper; Roberto A Nordaby; Jorge O Vilariño; Antonio Paragano; José L Cacharrón; Rogelio A Machado
Journal:  Cardiovasc Diabetol       Date:  2006-02-23       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.